Add like
Add dislike
Add to saved papers

A treatment and outcomes analysis of patients with coccydynia.

BACKGROUND CONTEXT: Coccydynia is a painful condition of the terminal portion of the spine often resulting from direct trauma, childbirth or unknown etiology. This is a relatively rare condition with no universally accepted treatment protocol.

PURPOSE: To more clearly determine the optimal treatment for patients with coccydynia and to assess the outcomes after conservative and surgical therapy.

STUDY DESIGN: Retrospective review of outcomes of all patients presenting with symptoms of coccydynia during a 5-year period.

PATIENT SAMPLE: Thirty-two patients presented to an orthopedic spine surgeon during a 5-year period with symptoms of coccydynia.

OUTCOME MEASURES: Patients completed visual analog pain scales (VAS) and the Oswestry (OSW) functional capacity index.

METHODS: Of the 32 patients in the study, 4 (13%) were treated with nonsteroidal anti-inflammatory drugs (NSAIDs) alone, 17 (53%) were treated with NSAIDs followed by local injections and 11 (34%) underwent coccygectomy after failure of NSAIDs and local injections. Patients completed VAS and OSW forms. Pain drawings were also completed.

RESULTS: Patients undergoing surgery had significantly greater pretreatment VAS scores (8.3 vs 5.4, p=.002). Surgical patients also had greater OSW scores, but not significantly (36.6 vs 24.2, p=.223). Marked improvement was reported by 9 of 11 (82%) surgical patients. Three of 11 (27%) surgical patients developed wound infections and 1 (9%) wound dehiscence. All infections resolved following irrigation and debridement and a short course of oral antibiotics.

CONCLUSIONS: Patients with coccydynia should be managed conservatively when possible. Treatment should include NSAIDs and local steroid injections. Patients will often require repeat injections over time. Surgery can offer reasonable results for patients failing conservative treatment, but they should be warned of the high rate of infection.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

For the best experience, use the Read mobile app

Group 7SearchHeart failure treatmentPapersTopicsCollectionsEffects of Sodium-Glucose Cotransporter 2 Inhibitors for the Treatment of Patients With Heart Failure Importance: Only 1 class of glucose-lowering agents-sodium-glucose cotransporter 2 (SGLT2) inhibitors-has been reported to decrease the risk of cardiovascular events primarily by reducingSeptember 1, 2017: JAMA CardiologyAssociations of albuminuria in patients with chronic heart failure: findings in the ALiskiren Observation of heart Failure Treatment study.CONCLUSIONS: Increased UACR is common in patients with heart failure, including non-diabetics. Urinary albumin creatininineJul, 2011: European Journal of Heart FailureRandomized Controlled TrialEffects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.Review

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

Read by QxMD is copyright © 2021 QxMD Software Inc. All rights reserved. By using this service, you agree to our terms of use and privacy policy.

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app